Literature DB >> 16299792

Improving outcomes after esophagectomy: the impact of operative volume.

Alan G Casson1, J Jan B van Lanschot.   

Abstract

Once considered an uncommon malignancy, primary esophageal adenocarcinoma has increased steadily in incidence over the past three decades. Despite advances in multimodality therapy, the prognosis for this tumor is generally poor. Surgical resection and reconstruction of the upper gastrointestinal tract is the current standard of care for localized esophageal cancer, but despite advances in perioperative care, still remains a relatively high-risk surgical procedure. Increasing numbers of reports published over the past decade have documented a clear volume-outcome relationship for several complex surgical procedures, and in particular for esophagectomy. The clinical implications of this association are reviewed in this section. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 16299792     DOI: 10.1002/jso.20368

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  13 in total

1.  A rehabilitation program for patients with gastroesophageal cancer--a pilot study.

Authors:  Martin Robert Chasen; Ravi Bhargava
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

2.  An update: the operative experience in adrenal, pancreatic, and other less common endocrine diseases of U.S. general surgery residents.

Authors:  David Le; Shahzeer Karmali; Jay K Harness; Brett C Sheppard
Journal:  World J Surg       Date:  2008-02       Impact factor: 3.352

3.  Effect of alpha-tocopherol, N-acetylcysteine and omeprazole on esophageal adenocarcinoma formation in a rat surgical model.

Authors:  Jing Hao; Bin Zhang; Ba Liu; Maojung Lee; Xingpei Hao; Kenneth R Reuhl; Xiaoxin Chen; Chung S Yang
Journal:  Int J Cancer       Date:  2009-03-15       Impact factor: 7.396

Review 4.  Robotic esophagectomy: the Moffitt Cancer Center experience.

Authors:  Marisa Amaral; Jose Pimiento; Jacques P Fontaine
Journal:  Ann Cardiothorac Surg       Date:  2017-03

5.  Margin Positivity in Resectable Esophageal Cancer: Are there Modifiable Risk Factors?

Authors:  Cary Jo R Schlick; Rhami Khorfan; David D Odell; Ryan P Merkow; David J Bentrem
Journal:  Ann Surg Oncol       Date:  2020-01-13       Impact factor: 5.344

6.  Results of adrenal surgery. Data of a Spanish National Survey.

Authors:  Jesús María Villar; Pablo Moreno; Joaquín Ortega; Elisabeth Bollo; César Pablo Ramírez; Nuria Muñoz; Cristina Martínez; Eduardo Domínguez-Adame; Juan Sancho; José Miguel del Pino; José Manuel Couselo; Ana Carrión; Marifé Candel; Nieves Cáceres; José María Octavio; Francisco Mateo; Lourdes Galán; José Manuel Ramia; Javier Aguiló; Francisco Herrera
Journal:  Langenbecks Arch Surg       Date:  2010-07-25       Impact factor: 3.445

7.  The effect of age on the outcome of esophageal cancer surgery.

Authors:  Abbas Alibakhshi; Ali Aminian; Rasoul Mirsharifi; Yosra Jahangiri; Habibollah Dashti; Faramarz Karimian
Journal:  Ann Thorac Med       Date:  2009-04       Impact factor: 2.219

8.  Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia.

Authors:  Martin Sundelöf; Jesper Lagergren; Weimin Ye
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

9.  The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence?

Authors:  Robert A Meguid; Eric S Weiss; David C Chang; Malcolm V Brock; Steven C Yang
Journal:  J Thorac Cardiovasc Surg       Date:  2009-01       Impact factor: 5.209

10.  Gastroesophageal reflux leads to esophageal cancer in a surgical model with mice.

Authors:  Jing Hao; Ba Liu; Chung S Yang; Xiaoxin Chen
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.